Flexion Therapeutics, Inc. (FLXN)

[whytestocks]

News: $FLXN Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

Pooled analysis published in Pain and Therapy indicated that the number of rescue medication tablets used per day through Week 24 was significantly less for ZILRETTA versus placebo and triamcinolone acetonide crystalline suspension (TAcs) Reduced rescue medication use further supports ...

Find out more https://marketwirenews.com/news-releases/flexion-therapeutics-announces-publication-of-pooled-analysis-of-phase-2-3-data-on-use-of-rescue-medication-with-zilretta-xae-triamcinolone-acetonide-extended-release-injectable-suspension--8159442.html